Thrombosis and Haemostasis, Table of Contents Thromb Haemost 2000; 84(03): 522-523DOI: 10.1055/s-0037-1614059 Letters to the Editor Schattauer GmbH rFVIIa – Its Thrombogenicity Authors Author Affiliations L. M. Aledort 1 From The Mount Sinai School of Medicine, New York, USA Recommend Article Abstract Buy Article(opens in new window) Full Text References References 1 Hilgartner M, Aledort L, Andes A, Gill J. and the members of the FEIBA Study Group. Efficacy and Safety of Vapor-Heated Anti-Inhibitor Coagulant Complex in Hemophilia Patients. Transfusion 1990; 30: 626-30. 2 Peerlinck K, Vermylen J. Acute Myocardial Infarction Following Administration of Recombinant Activated Factor VII (Novo Seven) in a Patient with Haemophilia A and Inhibitor. Thromb Haemost 1999; 82: 1775-6. 3 Kerwood FR. Novo Nordisk (June 16,1995): Dear Doctor, letter to inform US investigators following FDA requirements. 4 Hedner U, Glazer S, Faich J. Recombinant Activated Factor VII in the Treatment of Bleeding Episodes in Patients with Inherited and Acquired Bleeding Disorders. Trans Med Rev 1993; 07: 78-83. 5 d’Oiron R, Ménart C, Trzeciak MC, Nurden P, Fressinaud E, Dreyfus M, Laurian Y, Negrier C. Recombinant factor VIIa in Glanzmann’s thrombasthenia: A potential therapeutic place. Thromb Heamost 2000; 83: 644-7. 6 Schulman S. for the rFVIIa-CI Group. Safety, Efficacy and Lessons from Continuous Infusion with rFVIIa. Haemophil 1998; 04: 564-7. 7 Juvonen E, Kolho E, Anttila VJ, Lommi J, Nissinen M, Rasi V. Helsinki University Central Hospital, Clinic of Internal Medicine, Central Hospital of Mikkeli, FRC Blood Transfusion Service, Helsinki, Finland. Acute Myocardial Infarction Complicating Therapy with FVIII followed by APCC and rFVIIa in a 26-Year-Old Man with Haemophilia A and FVIII Inhibitor. Haemophil 1998; 04: 338 (Abstract). 8 Clinical experience with NovoSeven: Summary of efficacy and safety. August 1996 9 European public assessment report on NovoSeven. 1996; 28: 10. 10 Turecek PL, Richter G, Muchitson EM, Pichler L, Schwarz HP, Morrissey J. Thrombogenicity of recombinant factor VIIa and recombinant soluble tissue factor in an in vivo rabbit model. Thromb Haemostas Abstracts; XVIth Congress of the International Society of Thrombosis and Haemostasis, Florence, Italy. June 6-12,1997; PS903: 222.
